240 related articles for article (PubMed ID: 22405131)
41. Despite inhibition of nuclear localization of NF-kappa B p65, c-Rel, and RelB, 17-beta estradiol up-regulates NF-kappa B signaling in mouse splenocytes: the potential role of Bcl-3.
Dai R; Phillips RA; Ahmed SA
J Immunol; 2007 Aug; 179(3):1776-83. PubMed ID: 17641044
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of interleukin-1beta -induced NF-kappa B activation by calcium/calmodulin-dependent protein kinase kinase occurs through Akt activation associated with interleukin-1 receptor-associated kinase phosphorylation and uncoupling of MyD88.
Chen BC; Wu WT; Ho FM; Lin WW
J Biol Chem; 2002 Jul; 277(27):24169-79. PubMed ID: 11976320
[TBL] [Abstract][Full Text] [Related]
43. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens.
Galien R; Evans HF; Garcia T
Mol Endocrinol; 1996 Jun; 10(6):713-22. PubMed ID: 8776731
[TBL] [Abstract][Full Text] [Related]
44. Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells.
Chen Z; Wang Y; Warden C; Chen S
J Steroid Biochem Mol Biol; 2015 May; 149():118-27. PubMed ID: 25683269
[TBL] [Abstract][Full Text] [Related]
45. Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients.
Thomsen KG; Lyng MB; Elias D; Vever H; Knoop AS; Lykkesfeldt AE; Lænkholm AV; Ditzel HJ
Breast Cancer Res Treat; 2015 Dec; 154(3):483-94. PubMed ID: 26585578
[TBL] [Abstract][Full Text] [Related]
46. Differential regulation of vascular smooth muscle nuclear factor kappa-B by G alpha q-coupled and cytokine receptors.
Abbott KL; Robida AM; Davis ME; Pavlath GK; Camden JM; Turner JT; Murphy TJ
J Mol Cell Cardiol; 2000 Mar; 32(3):391-403. PubMed ID: 10731439
[TBL] [Abstract][Full Text] [Related]
47. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
[TBL] [Abstract][Full Text] [Related]
48. Serine protease inhibitor, 4-(2-aminoethyl)-benzene sulfonyl fluoride, impairs IL-12-induced activation of pSTAT4β, NFκB, and select pro-inflammatory mediators from estrogen-treated mice.
Karpuzoglu E; Gogal RM; Ansar Ahmed S
Immunobiology; 2011 Dec; 216(12):1264-73. PubMed ID: 21813204
[TBL] [Abstract][Full Text] [Related]
49. Physiologically high concentrations of 17beta-estradiol enhance NF-kappaB activity in human T cells.
Hirano S; Furutama D; Hanafusa T
Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1465-71. PubMed ID: 17194723
[TBL] [Abstract][Full Text] [Related]
50. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site.
Galien R; Garcia T
Nucleic Acids Res; 1997 Jun; 25(12):2424-9. PubMed ID: 9171095
[TBL] [Abstract][Full Text] [Related]
51. ERα36-GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells.
Notas G; Panagiotopoulos A; Vamvoukaki R; Kalyvianaki K; Kiagiadaki F; Deli A; Kampa M; Castanas E
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299224
[TBL] [Abstract][Full Text] [Related]
52. Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB.
Kalli K; Huntoon C; Bell M; McKean DJ
Mol Cell Biol; 1998 Jun; 18(6):3140-8. PubMed ID: 9584155
[TBL] [Abstract][Full Text] [Related]
53. 17Beta-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor alpha signaling in macrophages in vivo.
Calippe B; Douin-Echinard V; Delpy L; Laffargue M; Lélu K; Krust A; Pipy B; Bayard F; Arnal JF; Guéry JC; Gourdy P
J Immunol; 2010 Jul; 185(2):1169-76. PubMed ID: 20554954
[TBL] [Abstract][Full Text] [Related]
54. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
[TBL] [Abstract][Full Text] [Related]
55. Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model.
Heneweer M; Muusse M; Dingemans M; de Jong PC; van den Berg M; Sanderson JT
Toxicol Sci; 2005 Feb; 83(2):257-63. PubMed ID: 15525692
[TBL] [Abstract][Full Text] [Related]
56. Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling.
Oberbeck S; Schrader A; Warner K; Jungherz D; Crispatzu G; von Jan J; Chmielewski M; Ianevski A; Diebner HH; Mayer P; Kondo Ados A; Wahnschaffe L; Braun T; Müller TA; Wagle P; Bouska A; Neumann T; Pützer S; Varghese L; Pflug N; Thelen M; Makalowski J; Riet N; Göx HJM; Rappl G; Altmüller J; Kotrová M; Persigehl T; Hopfinger G; Hansmann ML; Schlößer H; Stilgenbauer S; Dürig J; Mougiakakos D; von Bergwelt-Baildon M; Roeder I; Hartmann S; Hallek M; Moriggl R; Brüggemann M; Aittokallio T; Iqbal J; Newrzela S; Abken H; Herling M
Blood; 2020 Dec; 136(24):2786-2802. PubMed ID: 33301031
[TBL] [Abstract][Full Text] [Related]
57. Selective modulation of lymphoproliferation and cytokine production via intracellular signaling targets by α1- and α2-adrenoceptors and estrogen in splenocytes.
Priyanka HP; ThyagaRajan S
Int Immunopharmacol; 2013 Nov; 17(3):774-84. PubMed ID: 24055020
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of Bcl3 gene expression mediates the anti-proliferative action of estrogen in pituitary lactotrophs in primary culture.
Mitsui T; Ishida M; Izawa M; Kagami Y; Arita J
Mol Cell Endocrinol; 2011 Oct; 345(1-2):68-78. PubMed ID: 21787835
[TBL] [Abstract][Full Text] [Related]
59. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.
Quaedackers ME; Van Den Brink CE; Wissink S; Schreurs RH; Gustafsson JA; Van Der Saag PT; Van Der Burg BB
Endocrinology; 2001 Mar; 142(3):1156-66. PubMed ID: 11181531
[TBL] [Abstract][Full Text] [Related]
60. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
Yamaguchi N; Nakayama Y; Yamaguchi N
J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
